GLP-1 Coverage Expands: Employer Programs and Medicare Pilot
Key Questions
How are employers changing GLP-1 drug coverage?
Employers are linking GLP-1 coverage to participation in lifestyle programs as part of a holistic approach to weight-loss drug access.
What is the new Medicare pilot program for GLP-1 drugs?
Medicare will cover GLP-1 drugs at $50 per month starting July 1, 2026, under a pilot program that runs through 2027, improving affordability for older adults.
When does Medicare GLP-1 coverage at $50/month begin?
Coverage under the pilot begins July 1, 2026, and continues through 2027 for eligible beneficiaries.
Who benefits from the Medicare GLP-1 pilot program?
The program provides significant savings for older adults by reducing co-pays to $50 per month for covered GLP-1 weight-loss drugs.
What uncertainties remain about GLP-1 coverage?
Questions persist regarding long-term coverage beyond the pilot and the strength of evidence supporting use in older populations.
Employers are linking GLP-1 coverage to lifestyle program participation, reflecting a holistic approach to weight-loss drug access. Now, Medicare will cover GLP-1 drugs at $50/month starting July 1, 2026, under a pilot program through 2027—a major affordability update for older adults. Questions remain about long-term coverage and evidence in older populations.